BioSpace News Archive

Browse BioSpace’s published news and press releases by year, month, and day.
192 Results
Year
Month
Day
  • Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today the pricing of its underwritten public follow-on offering (the “Follow-on Offering”) of 1,500,000 ordinary shares at a public offering price of US$15.00 per ordinary share (the “Offering Price”), for gross proceeds of $22,500,000.
  • Leyden Laboratories B.V., (the “Company” or “Leyden Labs”) today announced closing a $140M Series B financing, bringing its total capital raised to approximately $200M in 2021.